DHART SPORE Developmental Research Program (DRP) & Career Enhancement Program (CEP) Awards support researchers studying tumors in NF1 and other inherited Rasopathy syndromes to improve diagnosis and management.
DHART SPORE DRP and CEP awards are now listed with a December 1, 2026 submission deadline. The listing includes version 3.0 guidelines for both programs.
Funder: Indiana Clinical and Translational Sciences Institute
Due Dates: December 1, 2026 (Submission deadline)
Funding Amounts: $50,000–$75,000 per project for 12 months, supporting up to three DRP and three CEP projects
Summary: Supports research to improve tumor diagnosis and management in people with NF1 and other inherited Rasopathy syndromes.
The Developmental and Hyperactive Ras Tumor (DHART) SPORE program supports research to improve the diagnosis and management of tumors arising in people with neurofibromatosis type 1 (NF1) and other inherited “Rasopathy” syndromes. Offered through the Indiana Clinical and Translational Sciences Institute, the program brings together basic, translational, and clinical investigation around tumors associated with these inherited conditions.
Two distinct funding opportunities are available: the Developmental Research Program (DRP) and the Career Enhancement Program (CEP). Both support project work within the DHART SPORE research focus. Each opportunity has separate guidelines governing eligibility and application requirements.